NCT04361695

Brief Summary

Preemptive analgesia with the spinal anesthesia allows to decrease pain in hemorrhoidectomy postoperative period. The purpose of this study is to assess the effectiveness of the use of preemptive analgesia with spinal anesthesia to decrease postoperative pain and the amount of used analgesics including opioids.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 27, 2020

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

March 26, 2020

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2021

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2022

Completed
Last Updated

April 24, 2020

Status Verified

April 1, 2020

Enrollment Period

12 months

First QC Date

March 26, 2020

Last Update Submit

April 23, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The frequency of opioid analgesics usage

    The frequency of opioid administration per day

    0-7 days postoperatively

Secondary Outcomes (7)

  • Severity of pain

    6, 12 and 24 hours after the operation, then 2 times per day up to 7th postoperative day

  • Duration of other analgesics usage

    0-7 days postoperatively

  • Frequency of other analgesics usage

    0-7 days postoperatively

  • Re-admission rate

    30 days postoperatively

  • Overall quality of life

    7th and 30th days postoperatively

  • +2 more secondary outcomes

Study Arms (2)

Ketoprophenum

ACTIVE COMPARATOR

A tablet with 10 mg Ketoprophenum is taken per os 2 hours before surgery

Procedure: HemorrhoidectomyDrug: Ketoprophenum

Placebo

PLACEBO COMPARATOR

A tablet containing starch is taken per os 2 hours before surgery

Procedure: HemorrhoidectomyDrug: Placebo

Interventions

The patient receives spinal anaesthesia and is placed in lithotomy position. A complex of external and internal haemorrhoid or internal haemorrhoid only is excised with monopolar electrocautery or bipolar electrosurgery device. Haemorrhoid pedicle is tied with absorbable polyfilament suture. One, two or three nodes can be removed per a procedure.

KetoprophenumPlacebo

Ketoprophenum

Ketoprophenum

Placebo

Placebo

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent.
  • Patients over 18 years.
  • Symptomatic grade III-IV haemorrhoids.
  • Planned surgery: Milligan-Morgan hemorrhoidectomy

You may not qualify if:

  • Patient's refusal to participate in the study.
  • Pregnancy.
  • Contraindication or technical inability to perform subarachnoid anaesthesia.
  • Decompensated somatic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic of Colorectal and Minimally Invasive Surgery

Moscow, 119435, Russia

RECRUITING

Related Publications (1)

  • Kazachenko E, Garmanova T, Derinov A, Markaryan D, Lee H, Magbulova S, Tsarkov P. Preemptive analgesia for hemorrhoidectomy: study protocol for a prospective, randomized, double-blind trial. Trials. 2022 Jun 27;23(1):536. doi: 10.1186/s13063-022-06107-0.

MeSH Terms

Interventions

Hemorrhoidectomy

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Petr Tsarkov, Professor

    Russian Society of Colorectal Surgeons

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tatiana Garmanova, PhD

CONTACT

Daniil Markaryan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2020

First Posted

April 24, 2020

Study Start

February 27, 2020

Primary Completion

February 25, 2021

Study Completion

August 25, 2022

Last Updated

April 24, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations